E-LIB Suche - Ergebnisse für: Schjesvold, Fredrik, H

1

Health-related quality of life in relapsed/refractory multi..:

Schjesvold, Fredrik H. ; Ludwig, Heinz ; Delimpasi, Sossana...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Efficacy and safety of melflufen plus daratumumab and dexam..:

Pour, Luděk ; Szarejko, Monika ; Bila, Jelena...
Haematologica. 109 (2023) 3 - p. 895-905 , 2023

Link: https://doi.org/10.3324/..

3

Benefit Versus Risk Assessment of Melflufen and Dexamethaso..:

Sonneveld, Pieter ; Richardson, Paul G. ; Ludwig, Heinz...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 9 - p. 687-696 , 2023

Link: https://doi.org/10.1016/..

4

Melflufen in relapsed/refractory multiple myeloma refractor..:

Schjesvold, Fredrik H. ; Ludwig, Heinz ; Mateos, Maria‐Victoria...
European Journal of Haematology. , 2023

Link: https://doi.org/10.1111/..

5

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ix..:

Groen, Kazimierz ; Schjesvold, Fredrik H. ; van der Holt, Bronno...
HemaSphere. 7 (2023) 9 - p. e940 , 2023

Link: https://doi.org/10.1097/..

6

Authors' reply: Perspective: The approval and withdrawal of..:

Schjesvold, Fredrik H ; Bakker, Nicolaas A ; Sonneveld, Pieter
Translational Oncology. 25 (2022) - p. 101528 , 2022

Link: https://doi.org/10.1016/..

7

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

8

Targeting BCL‐2 with venetoclax and dexamethasone in patien..:

Kaufman, Jonathan L. ; Gasparetto, Cristina ; Schjesvold, Fredrik H....
American Journal of Hematology. 96 (2021) 4 - p. 418-427 , 2021

Link: https://doi.org/10.1002/..

9

Melflufen for relapsed and refractory multiple myeloma:

Oriol, Albert ; Larocca, Alessandra ; Leleu, Xavier...
Expert Opinion on Investigational Drugs. 29 (2020) 10 - p. 1069-1078 , 2020

Link: https://doi.org/10.1080/..

10

Indirect CD4+ T‐cell‐mediated elimination of MHC IINEG tumo..:

Tveita, Anders A. ; Schjesvold, Fredrik H. ; Sundnes, Olav...
European Journal of Immunology. 44 (2014) 9 - p. 2625-2637 , 2014

Link: https://doi.org/10.1002/..

11

Ixazomib-Thalidomide-low dose dexamethasone induction follo..:

Sonja Zweegman ; Claudia A.M. Stege ; Einar Haukas...
Haematologica. 105 (2020) 12 - p. 2879-2882 , 2020

Link: https://doi.org/10.3324/..

12

Isatuximab plus pomalidomide and dexamethasone in elderly p..:

Fredrik H. Schjesvold ; Paul G. Richardson ; Thierry Facon...
Haematologica. 106 (2020) 4 - p. 1182-1187 , 2020

Link: https://doi.org/10.3324/..

13

Cobimetinib Alone and Plus Venetoclax With/Without Atezoliz..:

Schjesvold, F.H. (Fredrik H.) ; Lourenco-Paiva, B.D. (Bruno David) ; Ribrag, V. (Vincent)...
https://pubmed.ncbi.nlm.nih.gov/36450626/. , 2023

Link: https://hdl.handle.net/1..

14

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ix..:

Groen, Kazimierz ; Schjesvold, Fredrik H ; van der Holt, Bronno...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470677/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ix..:

Groen, Kazimierz ; Schjesvold, Fredrik H ; Van Der Holt, Bronno...
https://pure.au.dk/portal/da/publications/ixazomibthalidomidedexamethasone-induction-followed-by-ixazomib-or-placebo-maintenance-in-nontransplant-eligible-newly-diagnosed-multiple-myeloma-patients(d4804f1e-58c6-4373-9c3b-06b30cc72ea5).html. , 2023

Link: https://pure.au.dk/porta..